Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
|Articles|May 14, 2019
- LCGC Europe-05-01-2019
- Volume 32
- Issue 5
Vol 32 No 05 LCGC Europe May 2019 Regular Issue PDF
Click the title above to open the LCGC Europe May 2019 regular issue, Vol 32, No 05, in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Methods from Mars? Coping with Chromatographic Legaciesover 7 years ago
New Gas Chromatography Products for 2018–2019over 7 years ago
New Sample Preparation Products and Accessoriesover 7 years ago
Metabolomics 2019over 7 years ago
Modern Mobile Phase Design for HPLCAdvertisement
Related to this article
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
How can advanced separations, inert hardware, orthogonal methods, and AI solve key challenges in reliable GLP-1 peptide analysis workflows?
Liquid chromatography–tandem mass spectrometry (LC–MS/MS) reveals distinct sphingolipid patterns in anorexia and obesity.
Leon Niezen and Gert Desmet discuss uncertainty-driven LC method development, peak overlap, and moving from in silico to real data.
Leon Niezen and Gert Desmet describe how predictive uncertainty can make automated LC method development more reliable.
Liquid chromatography–mass spectrometry (LC–MS) serum profiling ties lysine compounds to lupus kidney disease.
Liquid chromatography-mass spectrometry (LC–MS) growth lifts Waters Q3; MOBILion ion mobility buy expands proteomics.
Advertisement
Advertisement
Trending on LCGC International
1
LC–MS/MS Dried Blood Spot Test for Galactosemia
2
GLP-1 Peptide Analysis: Challenges and Solutions
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
From 9000 Clues to a Clinical Test: Mass Spectrometry-Driven Lipidomics for Early Cancer Detection
5